Protagonist Therapeutics Statistics
Total Valuation
PTGX has a market cap or net worth of $2.09 billion. The enterprise value is $1.76 billion.
| Market Cap | 2.09B |
| Enterprise Value | 1.76B |
Important Dates
The next estimated earnings date is Thursday, August 1, 2024, after market close.
| Earnings Date | Aug 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PTGX has 58.65 million shares outstanding. The number of shares has increased by 25.75% in one year.
| Shares Outstanding | 58.65M |
| Shares Change (YoY) | +25.75% |
| Shares Change (QoQ) | +5.24% |
| Owned by Insiders (%) | 1.18% |
| Owned by Institutions (%) | 104.17% |
| Float | 43.07M |
Valuation Ratios
The trailing PE ratio is 14.11 and the forward PE ratio is 15.02.
| PE Ratio | 14.11 |
| Forward PE | 15.02 |
| PS Ratio | 6.62 |
| Forward PS | n/a |
| PB Ratio | 3.72 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 10.87 |
| EV / Sales | 5.60 |
| EV / EBITDA | 10.45 |
| EV / EBIT | 10.66 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.72, with a Debt / Equity ratio of 0.00.
| Current Ratio | 15.72 |
| Quick Ratio | 15.60 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.00 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 43.40% and return on invested capital (ROIC) is 25.97%.
| Return on Equity (ROE) | 43.40% |
| Return on Assets (ROA) | 39.60% |
| Return on Capital (ROIC) | 25.97% |
| Revenue Per Employee | $2.81M |
| Profits Per Employee | $1.45M |
| Employee Count | 112 |
| Asset Turnover | 0.77 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, PTGX has paid $3.33 million in taxes.
| Income Tax | 3.33M |
| Effective Tax Rate | 2.01% |
Stock Price Statistics
The stock price has increased by +78.29% in the last 52 weeks. The beta is 2.12, so PTGX's price volatility has been higher than the market average.
| Beta (5Y) | 2.12 |
| 52-Week Price Change | +78.29% |
| 50-Day Moving Average | 32.47 |
| 200-Day Moving Average | 25.43 |
| Relative Strength Index (RSI) | 57.19 |
| Average Volume (20 Days) | 1,577,549 |
Short Selling Information
The latest short interest is 2.04 million, so 3.48% of the outstanding shares have been sold short.
| Short Interest | 2.04M |
| Short Previous Month | 3.12M |
| Short % of Shares Out | 3.48% |
| Short % of Float | 4.74% |
| Short Ratio (days to cover) | 2.27 |
Income Statement
In the last 12 months, PTGX had revenue of $314.95 million and earned $162.11 million in profits. Earnings per share was $2.52.
| Revenue | 314.95M |
| Gross Profit | 314.95M |
| Operating Income | 148.68M |
| Pretax Income | 165.44M |
| Net Income | 162.11M |
| EBITDA | 168.74M |
| EBIT | 165.44M |
| Earnings Per Share (EPS) | $2.52 |
Balance Sheet
The company has $322.64 million in cash and $462,000 in debt, giving a net cash position of $322.17 million or $5.49 per share.
| Cash & Cash Equivalents | 322.64M |
| Total Debt | 462,000 |
| Net Cash | 322.17M |
| Net Cash Per Share | $5.49 |
| Equity (Book Value) | 560.44M |
| Book Value Per Share | 9.56 |
| Working Capital | 587.64M |
Cash Flow
In the last 12 months, operating cash flow was -$63.32 million and capital expenditures -$841,000, giving a free cash flow of -$64.16 million.
| Operating Cash Flow | -63.32M |
| Capital Expenditures | -841,000 |
| Free Cash Flow | -64.16M |
| FCF Per Share | -$1.05 |
Margins
Gross margin is 100.00%, with operating and profit margins of 47.21% and 51.47%.
| Gross Margin | 100.00% |
| Operating Margin | 47.21% |
| Pretax Margin | 52.53% |
| Profit Margin | 51.47% |
| EBITDA Margin | 53.57% |
| EBIT Margin | 52.53% |
| FCF Margin | -20.37% |
Dividends & Yields
PTGX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.75% |
| Shareholder Yield | -25.75% |
| Earnings Yield | 7.77% |
| FCF Yield | -3.08% |
Analyst Forecast
The average price target for PTGX is $40.00, which is 12.52% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $40.00 |
| Price Target Difference | 12.52% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 43.54% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PTGX has an Altman Z-Score of 19.76 and a Piotroski F-Score of 4.
| Altman Z-Score | 19.76 |
| Piotroski F-Score | 4 |